The role of perilipin in human obesity and insulin resistance.

The role of perilipin in human obesity and insulin resistance. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

The role of perilipin in human obesity and insulin resistance. Abstract Text:

E Shyong Tai,Jose M Ordovas,

PURPOSE OF REVIEW: More than 1.1 billion people worldwide are overweight or obese. We know that obesity is determined by a combination of environmental and genetic factors. Although hundreds of obesity candidate genes have been identified through different metabolic pathways, the fundamental basis of obesity resides with excessive storage of triacylglycerides in adipose tissue. RECENT FINDINGS: The mechanisms that control the storage and release of triacylglycerides in lipid droplets are complex and poorly understood; yet, they are likely to be crucial to the understanding of the regulation of body weight. In this regard, the family of perilipin, adipophilin and TIP47 proteins may play key roles in obesity. It has recently been shown that variants at the perilipin locus were associated with BMI and obesity risk in females from several population studies. Moreover, the reported interactions between perilipin and dietary factors may shed light on the complex relation between dietary intake and body weight changes observed on an individual basis. SUMMARY: These findings support an important role for PLIN as a candidate gene for obesity risk in humans as well as a modulator of dietary response to therapies aimed to reduce body weight and decrease metabolic syndrome risk.

The role of perilipin in human obesity and insulin resistance. Publishing Authors By Initials

ES Tai,JM Ordovas,

For similar proteins: phosphoproteins research abstracts see: proteins: phosphoproteins research

PUBMED ID PMID:

MEDLINE DATE:

The role of perilipin in human obesity and insulin resistance. Journal Published:

PUBLICATION TYPE: Review

Journal: Current opinion in lipidology

VOLUME: 18

Page Numbers: 152-6

Journal Abbreviation: Curr. Opin. Lipidol.

ISSN: 0957-9672

DAY: 3

MONTH: Apr

YEAR: 2007

The role of perilipin in human obesity and insulin resistance. Information

Number of References: 37

LANGUAGE: eng

NlmUniqueID: 9010000

The role of perilipin in human obesity and insulin resistance. Keywords Mesh Terms:

KEYWORDS: Phosphoproteins

MESH TERMS: metabolism

Chemical & Substance for Abstract: The role of perilipin in human obesity and insulin resistance. Information

Substance Name: perilipin

Registry Number: 0

Grant and Affiliation Information for The role of perilipin in human obesity and insulin resistance.

AFFILIATION: Department of Endocrinology, Singapore General Hospital, Singapore. eshyong@pacific.net.sg

Country: England

AGENCY: United States NHLBI

GRANT: HL54776

ACRONYM: HL

MEDLINETA: Curr Opin Lipidol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

The role of perilipin in human obesity and insulin resistance Related Publications

• APOA5 gene variation modulates the effects of dietary fat intake on body mass index and obesity risk in the Framingham Heart Study.
• Adiponectin gene variants are associated with insulin sensitivity in response to dietary fat consumption in caucasian men.
• Association between well-characterized lipoprotein-related genetic variants and carotid intimal medial thickness and stenosis: The Framingham Heart Study.
• Association of Common C-Reactive Protein (CRP) Gene Polymorphisms With Baseline Plasma CRP Levels and Fenofibrate Response: The GOLDN Study.
• Diet/genetic interactions and their effects on inflammatory markers.
• Fenofibrate effect on triglyceride and postprandial response of apolipoprotein A5 variants: the GOLDN study.
• Gender, a significant factor in the cross talk between genes, environment, and health.
• Genetic links between diabetes mellitus and coronary atherosclerosis.
• Genetic predisposition, nongenetic risk factors, and coronary infarct.
• Genetic variation at the perilipin locus is associated with changes in serum free fatty acids and abdominal fat following mild weight loss.
• Interleukin1beta genetic polymorphisms interact with polyunsaturated fatty acids to modulate risk of the metabolic syndrome.
• Metabolic syndrome pathophysiology: the role of adipose tissue.
• PPARGC1A Variation Associated With DNA Damage, Diabetes, and Cardiovascular Diseases: The Boston Puerto Rican Health Study.
• Perilipin polymorphism interacts with dietary carbohydrates to modulate anthropometric traits in hispanics of Caribbean origin.
• Postprandial triacylglycerol metabolism is modified by the presence of genetic variation at the perilipin (PLIN) locus in 2 white populations.
• Scavenger receptor class B type I (SCARB1) c.1119C>T polymorphism affects postprandial triglyceride metabolism in men.
• The -256T>C polymorphism in the apolipoprotein A-II gene promoter is associated with body mass index and food intake in the genetics of lipid lowering drugs and diet network study.
• The effect of IL6-174C/G polymorphism on postprandial triglyceride metabolism in the GOLDN studyboxs.
• The role of perilipin in human obesity and insulin resistance.
• Three different insertion polymorphisms 3' to the human apolipoprotein A-IV gene.
• Uncoupling protein 2 promoter polymorphism -866G/A, central adiposity, and metabolic syndrome in Asians.